Merriman Capital Announces Sponsorship of BioLight Life Sciences Investments Ltd. on OTCQX
SAN FRANCISCO - September 23, 2014 - Merriman Capital, Inc., a wholly owned subsidiary of Merriman Holdings, Inc. (MERR), announced today that it will serve as the Principal American Liaison (PAL) for BioLight Life Sciences Investments Ltd. (BLGTY) ("BioLight") as it continues trading on OTCQX®.
OTCQX is the premier tier of the OTC markets. OTCQX traded companies are distinguished from more than 9,000 securities traded Over-the-Counter. These companies meet more stringent financial standards and undergo a qualitative review process. For international issuers, a PAL is selected by an OTCQX traded company to serve as a liaison between the issuer and the U.S. market. The PAL can help the issuer communicate more effectively with the U.S. investment community by leveraging the PAL`s resources and capital markets experience. PAL eligibility is limited to FINRA member investment banks or ADR banks.
"We are pleased to welcome BioLight to our universe of high-quality OTCQX sponsored companies," commented Douglas Rogers, Managing Director of Merriman`s Capital Markets Advisory Group. "The OTCQX continues to represent nearly one-half of the advisory clients that we represent and we look forward to working closely with BioLight management to advise them on what we believe are best practices regarding dissemination of material information and financial reporting requirements the markets, as well as ongoing engagement with existing and prospective investors. We look forward to supporting the BioLight management team in our capacity as their PAL to the OTCQX market."
